Literature DB >> 31525912

Degronomics: Mapping the Interacting Peptidome of a Ubiquitin Ligase Using an Integrative Mass Spectrometry Strategy.

Daniele Canzani1, Domniţa-Valeria Rusnac2, Ning Zheng2, Matthew F Bush1.   

Abstract

Human cells make use of hundreds of unique ubiquitin E3 ligases to ensure proteome fidelity and control cellular functions by promoting protein degradation. These processes require exquisite selectivity, but the individual roles of most E3s remain poorly characterized in part due to the challenges associated with identifying, quantifying, and validating substrates for each E3. We report an integrative mass spectrometry (MS) strategy for characterizing protein fragments that interact with KLHDC2, a human E3 that recognizes the extreme C-terminus of substrates. Using a combination of native MS, native top-down MS, MS of destabilized samples, and liquid chromatography MS, we identified and quantified a near complete fraction of the KLHDC2-binding peptidome in E. coli cells. This degronome includes peptides that originate from a variety of proteins. Although all identified protein fragments are terminated by diglycine or glycylalanine, the preceding amino acids are diverse. These results significantly expand our understanding of the sequences that can be recognized by KLHDC2, which provides insight into the potential substrates of this E3 in humans. We anticipate that this integrative MS strategy could be leveraged more broadly to characterize the degronomes of other E3 ligase substrate receptors, including those that adhere to the more common N-end rule for substrate recognition. Therefore, this work advances "degronomics," i.e., identifying, quantifying, and validating functional E3:peptide interactions in order to determine the individual roles of each E3.

Entities:  

Year:  2019        PMID: 31525912      PMCID: PMC6959985          DOI: 10.1021/acs.analchem.9b02331

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  50 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Massign: an assignment strategy for maximizing information from the mass spectra of heterogeneous protein assemblies.

Authors:  Nina Morgner; Carol V Robinson
Journal:  Anal Chem       Date:  2012-03-07       Impact factor: 6.986

3.  Detection of potential ion suppression for peptide analysis in nanoflow liquid chromatography/mass spectrometry.

Authors:  Atsumu Hirabayashi; Masako Ishimaru; Naomi Manri; Toshiyuki Yokosuka; Hiroko Hanzawa
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

4.  Effects of polarity on the structures and charge states of native-like proteins and protein complexes in the gas phase.

Authors:  Samuel J Allen; Alicia M Schwartz; Matthew F Bush
Journal:  Anal Chem       Date:  2013-11-21       Impact factor: 6.986

Review 5.  Trans-Proteomic Pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics.

Authors:  Eric W Deutsch; Luis Mendoza; David Shteynberg; Joseph Slagel; Zhi Sun; Robert L Moritz
Journal:  Proteomics Clin Appl       Date:  2015-04-02       Impact factor: 3.494

6.  A proteomic screen reveals SCFGrr1 targets that regulate the glycolytic-gluconeogenic switch.

Authors:  Jennifer A Benanti; Stephanie K Cheung; Mariska C Brady; David P Toczyski
Journal:  Nat Cell Biol       Date:  2007-09-09       Impact factor: 28.824

7.  Top-down characterization of endogenous protein complexes with native proteomics.

Authors:  Owen S Skinner; Nicole A Haverland; Luca Fornelli; Rafael D Melani; Luis H F Do Vale; Henrique S Seckler; Peter F Doubleday; Luis F Schachner; Kristina Srzentić; Neil L Kelleher; Philip D Compton
Journal:  Nat Chem Biol       Date:  2017-11-13       Impact factor: 15.040

8.  MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics.

Authors:  Andy T Kong; Felipe V Leprevost; Dmitry M Avtonomov; Dattatreya Mellacheruvu; Alexey I Nesvizhskii
Journal:  Nat Methods       Date:  2017-04-10       Impact factor: 28.547

9.  How many human proteoforms are there?

Authors:  Ruedi Aebersold; Jeffrey N Agar; I Jonathan Amster; Mark S Baker; Carolyn R Bertozzi; Emily S Boja; Catherine E Costello; Benjamin F Cravatt; Catherine Fenselau; Benjamin A Garcia; Ying Ge; Jeremy Gunawardena; Ronald C Hendrickson; Paul J Hergenrother; Christian G Huber; Alexander R Ivanov; Ole N Jensen; Michael C Jewett; Neil L Kelleher; Laura L Kiessling; Nevan J Krogan; Martin R Larsen; Joseph A Loo; Rachel R Ogorzalek Loo; Emma Lundberg; Michael J MacCoss; Parag Mallick; Vamsi K Mootha; Milan Mrksich; Tom W Muir; Steven M Patrie; James J Pesavento; Sharon J Pitteri; Henry Rodriguez; Alan Saghatelian; Wendy Sandoval; Hartmut Schlüter; Salvatore Sechi; Sarah A Slavoff; Lloyd M Smith; Michael P Snyder; Paul M Thomas; Mathias Uhlén; Jennifer E Van Eyk; Marc Vidal; David R Walt; Forest M White; Evan R Williams; Therese Wohlschlager; Vicki H Wysocki; Nathan A Yates; Nicolas L Young; Bing Zhang
Journal:  Nat Chem Biol       Date:  2018-02-14       Impact factor: 15.040

10.  The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons.

Authors:  Itay Koren; Richard T Timms; Tomasz Kula; Qikai Xu; Mamie Z Li; Stephen J Elledge
Journal:  Cell       Date:  2018-05-17       Impact factor: 41.582

View more
  2 in total

Review 1.  PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras.

Authors:  Jyotsana Madan; Vijay Kamal Ahuja; Kamal Dua; Susanta Samajdar; Murali Ramchandra; Sanjeev Giri
Journal:  BioDrugs       Date:  2022-09-13       Impact factor: 7.744

Review 2.  Higher-order structural characterisation of native proteins and complexes by top-down mass spectrometry.

Authors:  Mowei Zhou; Carter Lantz; Kyle A Brown; Ying Ge; Ljiljana Paša-Tolić; Joseph A Loo; Frederik Lermyte
Journal:  Chem Sci       Date:  2020-10-20       Impact factor: 9.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.